ly3537982
amgen,eli lilly,revolution medicines,mirati therapeutics
['solid tumor', 'ly3537982', '$amgn', '$lly', '$mrtx', '$rvmd']
$lly ct028 - a first-in-human phase 1 study of ly3537982, a highly selective and potent kras g12c inhibitor in patients with kras g12c-mutant advanced solid tumors #aacr23 $mrtx $amgn $rvmd 
L/S biotech. PhD student @UniofOxford